CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVS

AAA617

Phase 3
Novartis AG (NVS)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Oct '26
NVSPhase 2

AAA617 Phase 2 Est. Readout (PSMAndARPI)

AAA617
Oct 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Oligometastatic Prostate Cancer (OMPC)

View Full Landscape
Drug Information

Target Indication

Oligometastatic Prostate Cancer (OMPC)

Clinical Trial

NCT05939414

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.